Key result
The tumor-to-normal ratio of ANGPTL2 mRNA levels was higher in lymph node metastasis-positive non-small cell lung cancer cases compared with metastasis-negative cases.
Why the study?
Does ANGPTL2 gene expression correlate with lymph node metastasis and survival in patients with surgically resected NSCLC?
Observational (n=110)
No
Does ANGPTL2 gene expression correlate with lymph node metastasis and survival in patients with surgically resected NSCLC?
ANGPTL2 mRNA expression is significantly elevated in NSCLC with lymph node metastasis, suggesting it may play a role in the metastatic process, though it did not correlate with overall survival.
Answers are grounded in this paper and cite their sources.
ANGPTL2 ratio associates with lymph node metastasis in resected NSCLC; leaves open survival link and clinical utility pending validation.
Inflammation plays key roles at various stages of tumor development, including invasion and metastasis. In mice, the angiopoietin-like protein (ANGPTL2) gene has been implicated in inflammatory carcinogenesis. ANGPTL2 mRNA expression was investigated by real-time polymerase chain reaction (RT-PCR) assay using LightCycler in surgically treated non-small cell lung cancer (NSCLC) cases. In total, 110 surgically resected NSCLC cases were used for mRNA level analyses. The ANGPTL2/β-actin mRNA levels were not significantly different between lung cancer (1598.481±6465.781) and adjacent normal lung tissues (2116.639±8337.331, P=0.5453). The tumor/normal (T/N) ratio of ANGPTL2/β-actin mRNA levels was not different between gender, age, smoking status and pathological stages. The T/N ratio of ANGPTL2/β-actin mRNA levels was significantly higher in lymph node metastasis-positive cases (2.173±3.151) compared with lymph node metastasis-negative cases (1.212±1.778, P=0.0464). However, ANGPTL2 mRNA status was not correlated with tumor invasion status. Thus, ANGPTL2 may drive metastasis and provide a candidate for blockade of its function as a strategy to antagonize the metastatic process in NSCLC.
No takes yet. Share an insight, caveat, or question.
Sasaki et al. (2012) conducted an observational in Non-small cell lung cancer (NSCLC) (n=110). Lymph node metastasis vs. No lymph node metastasis was evaluated on Tumor/normal (T/N) ratio of ANGPTL2/β-actin mRNA levels (p=0.0464). The tumor-to-normal ratio of ANGPTL2 mRNA levels was higher in lymph node metastasis-positive non-small cell lung cancer cases compared with metastasis-negative cases.
Synapse has enriched 10 related papers. Consider them for comparative context: